HEIDI FURTH: Open Payments
NPI 1669530671 · SIOUX FALLS, SD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,040 in 52 payments from 13 companies in 2025. Trend: 2023 $1,498 · 2024 $1,220 · 2025 $1,040
Food & beverage: $940Education: $100
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 11 | $184 |
| Janssen Biotech, Inc. | 5 | $177 |
| Novartis Pharmaceuticals Corporation | 7 | $121 |
| Amgen Inc. | 6 | $112 |
| Regeneron Healthcare Solutions, Inc. | 4 | $102 |
| Lilly USA, LLC | 5 | $91 |
| UCB, Inc. | 3 | $69 |
| LEO Pharma Inc. | 3 | $53 |
| PFIZER INC. | 3 | $47 |
| Arcutis Biotherapeutics, Inc. | 2 | $36 |
Products named: DUPIXENT, TREMFYA, OTEZLA, COSENTYX, Bimzelx, TALTZ, CIBINQO, EBGLYSS.
Industry payments across SD — which companies pay providers there.
